PE72599A1 - Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros - Google Patents

Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros

Info

Publication number
PE72599A1
PE72599A1 PE1998000335A PE00033598A PE72599A1 PE 72599 A1 PE72599 A1 PE 72599A1 PE 1998000335 A PE1998000335 A PE 1998000335A PE 00033598 A PE00033598 A PE 00033598A PE 72599 A1 PE72599 A1 PE 72599A1
Authority
PE
Peru
Prior art keywords
cox
alkyl
carprophen
phenyl
dogs
Prior art date
Application number
PE1998000335A
Other languages
English (en)
Spanish (es)
Inventor
Lundy Kristin Marie Marie
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PE72599A1 publication Critical patent/PE72599A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
PE1998000335A 1997-05-05 1998-05-04 Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros PE72599A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05

Publications (1)

Publication Number Publication Date
PE72599A1 true PE72599A1 (es) 1999-08-12

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000335A PE72599A1 (es) 1997-05-05 1998-05-04 Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros

Country Status (32)

Country Link
EP (1) EP0988034A1 (fr)
JP (1) JP2000513020A (fr)
KR (2) KR20010012300A (fr)
CN (1) CN1255059A (fr)
AP (1) AP9801234A0 (fr)
AR (2) AR011726A1 (fr)
AU (1) AU6932198A (fr)
BG (1) BG103852A (fr)
BR (1) BR9808720A (fr)
CA (1) CA2288759A1 (fr)
DZ (1) DZ2479A1 (fr)
EA (1) EA003696B1 (fr)
GT (1) GT199800063A (fr)
HR (1) HRP980244A2 (fr)
HU (1) HUP0001286A3 (fr)
ID (1) ID21311A (fr)
IL (1) IL132570A0 (fr)
IS (1) IS5220A (fr)
MA (1) MA26491A1 (fr)
NO (1) NO995389L (fr)
NZ (1) NZ500183A (fr)
OA (1) OA11213A (fr)
PA (1) PA8450601A1 (fr)
PE (1) PE72599A1 (fr)
PL (1) PL337003A1 (fr)
SK (1) SK148199A3 (fr)
TN (1) TNSN98059A1 (fr)
TW (1) TW590773B (fr)
UY (1) UY24989A1 (fr)
WO (1) WO1998050033A1 (fr)
YU (1) YU55899A (fr)
ZA (1) ZA983722B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU764872B2 (en) * 1998-10-23 2003-09-04 Merck Frosst Canada & Co. Combination product comprising an E-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
CA2363590A1 (fr) * 1999-03-10 2000-09-14 G.D. Searle & Co. Procede et composition se rapportant a l'administration d'un inhibiteur de la cyclo-oxygenase-2
WO2001034204A1 (fr) * 1999-11-11 2001-05-17 Eli Lilly And Company Produits composes oncolytiques destines au traitement du cancer
EP1283723A2 (fr) * 2000-05-15 2003-02-19 Merck Frosst Canada & Co. Polytherapie faisant appel a un inhibiteur selectif de cox-2 et a un inhibiteur de la thromboxane ainsi que des compositions contenant ceux-ci
CN100588395C (zh) 2000-06-13 2010-02-10 Wyeth公司 含有环氧化酶-2抑制剂的止痛和抗炎药物
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
AU8474701A (en) 2000-08-07 2002-02-18 Univ Vanderbilt Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites
AU2002354901A1 (en) * 2001-07-16 2003-03-03 Edward Hogestatt Compounds with analgesic, antipyretic and/or anti-inflammatory activity
PT1534305E (pt) 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
JP2007500691A (ja) * 2003-07-31 2007-01-18 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗炎症剤の分散性製剤
BRPI0610316A2 (pt) * 2005-05-20 2010-06-15 Pfizer Ltd combinações sinergìsticas de medicamentos atiinflamatórios não estereoidais com alfa-delta-ligantes
EP2061440A2 (fr) 2007-04-04 2009-05-27 Sigmoid Pharma Limited Composition pharmaceutique à base de tacrolimus
ES2963291T3 (es) 2007-04-26 2024-03-26 Sublimity Therapeutics Ltd Fabricación de múltiples minicápsulas
EP2471518B1 (fr) 2009-05-18 2017-08-23 Sigmoid Pharma Limited Composition comprenant des gouttes d'huile
EP2464341B1 (fr) 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Compositions immunomodulatrices comprenant une matrice polymère et une phase huileuse
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
TWI664969B (zh) 2014-03-06 2019-07-11 雅瑞塔那醫療公司 格拉匹綸(ｇｒａｐｉｐｒａｎｔ)組合物及其使用方法
WO2016071515A1 (fr) 2014-11-07 2016-05-12 Sigmoid Pharma Limited Compositions comprenant de la cyclosporine
EP3242557A4 (fr) * 2015-01-09 2018-09-05 Jaguar Health, Inc. Méthodes de traitement de la diarrhée chez des animaux de compagnie
CN115335046A (zh) * 2020-03-25 2022-11-11 思研（Sri）国际顾问与咨询公司 脂肪氧合酶抑制剂
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (fr) * 1987-02-03 1993-07-06 Alberto Ferro Solutions de micelles mixtes

Also Published As

Publication number Publication date
JP2000513020A (ja) 2000-10-03
ZA983722B (en) 1999-11-04
SK148199A3 (en) 2001-09-11
BG103852A (en) 2000-06-30
AR011726A1 (es) 2000-08-30
EP0988034A1 (fr) 2000-03-29
CN1255059A (zh) 2000-05-31
HRP980244A2 (en) 1999-02-28
WO1998050033A1 (fr) 1998-11-12
KR20040004406A (ko) 2004-01-13
NO995389D0 (no) 1999-11-04
IS5220A (is) 1999-10-19
AU6932198A (en) 1998-11-27
OA11213A (en) 2003-07-14
KR20010012300A (ko) 2001-02-15
HUP0001286A2 (hu) 2000-11-28
EA199900895A1 (ru) 2000-06-26
YU55899A (sh) 2003-08-29
EA003696B1 (ru) 2003-08-28
HUP0001286A3 (en) 2000-12-28
TNSN98059A1 (fr) 2005-03-15
TW590773B (en) 2004-06-11
PL337003A1 (en) 2000-07-31
MA26491A1 (fr) 2004-12-20
BR9808720A (pt) 2000-07-11
AP9801234A0 (en) 1999-11-04
UY24989A1 (es) 2001-10-25
NZ500183A (en) 2002-04-26
CA2288759A1 (fr) 1998-11-12
NO995389L (no) 2000-01-04
AR039628A2 (es) 2005-03-02
IL132570A0 (en) 2001-03-19
ID21311A (id) 1999-05-20
GT199800063A (es) 1999-10-26
PA8450601A1 (es) 2000-05-24
DZ2479A1 (fr) 2003-02-01

Similar Documents

Publication Publication Date Title
ES2082875T3 (es) 3,5-di-terc-butil-4-hidroxifenilmetileno-derivados de tiazolidinonas, oxazolidinonas e imidazolidinonas 2-sustituidas utiles como agentes antiinflamatorios.
PE108099A1 (es) Acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
NI200300042A (es) Compuestos que modulan la actividad de ppar y metodos para su preparacion.
AR027518A1 (es) Inhibidores de girasas y usos de los mismos
AR036114A1 (es) Tetrahidroimidazol[1,2-a]pirazinas y tetrahidrotriazol[4,3-a]pirazinas como inhibidores de la dipeptidil peptidasa utiles para el tratamiento o la prevencion de la diabetes
PE20091065A1 (es) Derivados bis-(sulfonilamino) en terapia 066
CR7865A (es) Derivados de dihidropiranoindol -3,4-diona sustituidos y derivados de 2-hidroximetilindol del acido 3-oxoacetico sustituidos como inhibidores del inhibidor del activador del plasminogeno 1(pai-1)
PY0301561A (es) Compuestos heterociclicos, inhibidores de beta-lactamasas
ES2177112T3 (es) Agentes angiostaticos y composiciones para tratar el glaucoma glc1a.
AR029215A1 (es) Derivados de benzazol y tautomeros de los mismos utiles en el tratamiento de desordenes en los sistemas de autoinmunidad y neuronales, uso de dichos derivados en la preparacion de composiciones farmaceuticas aplicables en el tratamiento de dichos desordenes, metodo prar inhibir la expresion y/o acti
PE20040411A1 (es) Compuestos de aril cetona pirrolo triazina
ES2192588T3 (es) 4-(arilaminometilen)-2,4-dihidro-pirazol-3-onas.
UY27370A1 (es) Derivados de benzamida tiazol y composiciones farmacéuticas para inhibir la proliferación de células y métodos para su utilización
ES2058342T3 (es) Pirroles, pirazoles y triazoles sustituidos antagonistas de la angiotensina ii.
ES2069410T3 (es) Nuevos derivados del acido hidroxamico y n-hidroxiurea y su uso.
NI200500087A (es) Derivados 4-tetrazolyl-4 fenilpiperidina para el tratamiento del dolor
ES2164924T3 (es) Antibioticos de cefalosporina.
UY28048A1 (es) Inhibidores de hiv-integrasa,composiciones farmacéuticas y métodos para su uso
ES543282A0 (es) Procedimiento para preparar nuevas bis-(4-aminofenil)-sulfo-nas substituidas
UY26847A1 (es) Derivados de la pirrolidina
AR125479A1 (es) Inhibidores de il4i1 y métodos de uso
SE9702563D0 (sv) Compounds
PE35196A1 (es) Derivado de benzamidina util como antagonista de ltb4
PE20211815A1 (es) Formas cristalinas de un inhibidor de fosfoinositida 3-quinasa (pi3k)
UY26895A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2

Legal Events

Date Code Title Description
FC Refusal